The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.95
Bid: 47.60
Ask: 47.95
Change: -1.10 (-2.24%)
Spread: 0.35 (0.735%)
Open: 49.40
High: 49.45
Low: 47.75
Prev. Close: 49.05
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

19 Jul 2017 07:00

RNS Number : 4400L
IP Group PLC
19 July 2017
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT, WHICH DOES NOT CONSTITUTE A PROSPECTUS OR DOCUMENT EQUIVALENT TO A PROSPECTUS, IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES AND NEITHER THIS ANNOUNCEMENT NOR ANYTHING HEREIN FORMS THE BASIS FOR ANY CONTRACT OR COMMITMENT WHATSOEVER. SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION AND THE SECURITIES DESCRIBED HEREIN WILL BE SOLD IN ACCORDANCE WITH ALL APPLICABLE LAWS AND REGULATIONS.

 

19 July 2017

 

IP Group plc

("IP Group" or the "Company")

 

Publication of Prospectus and Circular and Notice of General Meeting

 

Further to the offer for Touchstone Innovations plc announced on 20 June 2017 and the terms of the improved offer announced on 18 July 2017 (the "Offer"), IP Group announces that a circular and a prospectus relating to the Offer (the "Circular" and the "Prospectus") were approved by the UK Listing Authority yesterday.

 

The following documents were posted to Shareholders yesterday:

 

1. the Circular, including the Notice of General Meeting of the Company to be held at the office of the Company at The Walbrook Building, 25 Walbrook, London, EC4N 8AF at 11.00 a.m. on 10 August 2017; and

2. the Form of Proxy for use at the General Meeting.

 

The Circular and the Prospectus are available on the investor relations section of the Company's website www.ipgroupplc.com/investor-relations. Copies of the Circular and the Prospectus will be available from the registered office of the Company at The Walbrook Building, 25 Walbrook, London, EC4N 8AF and at the offices of Pinsent Masons LLP, 30 Crown Place, London EC2A 4ES, during usual business hours on any day (except Saturdays, Sundays and public holidays) from the date of publication until Admission. Capitalised terms not otherwise defined in this announcement shall have the meaning given to them in the Circular.

 

A copy of the Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.hemscott.com/nsm.do.

 

 

Enquiries:

 

IP Group plc

Alan Aubrey, Chief Executive Officer

+44 (0) 20 7444 0050

Greg Smith, Chief Financial Officer

+44 (0) 20 7444 0070

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Numis Securities Limited (Sponsor, Broker and Joint Financial Adviser)

+44(0) 20 7260 1000

 

Michael Meade

 

James Black

 

Freddie Barnfield

 

 

Rothschild (Lead Financial Adviser)

+44 (0) 20 7280 5000

 

Warner Mandel

 

Anton Black

 

 

Charlotte Street Partners

 

Andrew Wilson

+44 (0) 7810 636995

 

Martha Walsh

+44 (0) 7876 245962

 

 

 

IMPORTANT NOTICE

 

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Offer. Investors should not subscribe for or purchase any shares in IP Group except on the basis of the information contained in the Prospectus or which is incorporated by reference into the Prospectus. The Prospectus will be made available on the investor relations section of the Company's website (www.ipgroupplc.com/investor-relations) and will be available for inspection at: http://www.hemscott.com/nsm.do.

 

This announcement does not constitute or form part of any offer or invitation to purchase, or otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security in the capital of the Company in any jurisdiction.

 

The information contained in this announcement is not for release, publication or distribution to persons in the United States, Canada, Australia, Japan, New Zealand or the Republic of South Africa or in any jurisdiction where to do so would breach any applicable law. IP Group shares have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws. No public offer of IP Group shares is being made by virtue of this announcement into Australia, Canada, Japan, New Zealand, the Republic of South Africa or the United States or any other jurisdiction outside the United Kingdom in which such offer would be lawful. No action has been or will be taken by the Company, Numis Securities limited ("Numis"), N.M. Rothschild & Sons Limited ("Rothschild") or any other person to permit a public offering or distribution of this announcement or any other offering or publicity materials or IP Group shares in any jurisdiction where action for that purpose may be required, other than in the United Kingdom.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

 

This announcement has been issued by and is the sole responsibility of the Company.

 

Numis, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for IP Group plc and for no-one else in connection with the contents of this announcement and will not be responsible to anyone other than IP Group plc for providing the protections afforded to clients of Numis, or for providing advice in relation to the contents of this announcement or any matters referred to herein. Numis is not responsible for the contents of this announcement. Numis has given and not withdrawn its written consent to the issue of this announcement with the inclusion of the reference to its name in the form and context in which it is included.

 

Rothschild, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting for IP Group Plc and no-one else in connection with the contents of this announcement and will not be responsible to anyone other than IP Group Plc for providing the protections afforded to clients of Rothschild nor for providing advice in connection with the contents of this announcement or any matters referred to herein. Rothschild is not responsible for the contents of this announcement.

 

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIEAEXPFSAXEAF
Date   Source Headline
26th Oct 20236:10 pmRNSHolding(s) in Company
12th Oct 202310:20 amRNSWebinar on ESG & Impact
28th Sep 20234:28 pmRNSDirector/PDMR Shareholding; SAYE scheme
8th Aug 202310:00 amRNSTechnology trends webinar on AI
2nd Aug 20237:00 amRNSIP Group half-yearly results
13th Jul 20235:11 pmRNSDirector Declaration
12th Jul 20231:41 pmRNSTR-1: form for notification of major holdings
30th Jun 202310:23 amRNSTotal Voting Rights
29th Jun 20236:24 pmRNSDirector/PDMR Shareholding
28th Jun 202311:31 amRNSNotice of Results
26th Jun 202312:41 pmRNSDirector Declaration
15th Jun 20231:19 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
8th Jun 20238:51 amRNSLife Sciences update event
7th Jun 202311:00 amRNSIP Group plc - TR1 form
31st May 20232:34 pmRNSTotal Voting Rights
12th May 20231:26 pmRNSDirector Declaration
10th May 202312:11 pmRNSDirector/PDMR Shareholding
3rd May 202310:56 amRNSDirector Declaration
28th Apr 20233:21 pmRNSTotal Voting Rights
20th Apr 20235:00 pmRNSNotice of AGM, Annual Report
18th Apr 20233:23 pmRNSRSP & DBSP awards; Director/PDMR shareholding
15th Mar 20239:31 amRNSInvestor presentation
13th Mar 20239:00 amRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSNo direct deposits or credit facilities with SVB
8th Mar 20237:00 amRNSIP Group plc - Annual Results
2nd Mar 20233:25 pmRNSTR-1
21st Feb 20237:00 amRNSAMSL Aero's all-electric aircraft maiden flight
10th Feb 20239:55 amRNSNotice of Results
31st Jan 202310:00 amRNSTotal Voting Rights
30th Jan 20237:00 amRNSStatement re press speculation
24th Jan 20231:18 pmRNSForm 8.3 - Mirriad Advertising plc
18th Jan 20237:00 amRNSDirectorate Change
11th Jan 20237:00 amRNSPortfolio company Oxbotica raises $140m Series C
3rd Jan 202311:48 amRNSTotal Voting Rights
12th Dec 20224:58 pmRNSAGM post-meeting shareholder engagement update
7th Dec 20224:39 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIstesso announces FDA Fast Track for MBS2320
2nd Dec 202211:38 amRNSPortfolio company funding leads to £36m gain
30th Nov 202210:41 amRNSTotal Voting Rights
21st Nov 20222:13 pmRNSLife sciences presentation postponed
2nd Nov 20223:51 pmRNSInvestor presentation on life sciences
1st Nov 20228:59 amRNSNotification of major holdings
31st Oct 20224:35 pmRNSDirector/PDMR Shareholding
27th Oct 20224:55 pmRNSPDMR Dealing – SAYE Exercise
24th Oct 20226:02 pmRNSHolding(s) in Company
14th Oct 20229:42 amRNSHolding(s) in Company
30th Sep 202210:39 amRNSTotal Voting Rights
21st Sep 20225:29 pmRNSHolding(s) in Company
20th Sep 20226:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.